CREB3 showed strongly inhibitive effects on growth and metastasis of HCC in vitro and in vivo, due to decreasing the phosphorylation of AKT by competitively binding to INSR and transcriptionally activating RBM38 independently. Here, AKT1 is linked to hepatocellular carcinoma.